Fever and sickness behavior: Friend or foe?

Brain, Behavior, and Immunity

Volumn 50, Issue , 2015, Pages 322-333

  Harden, L M ^a   Kent, S ^b   Pittman, Q J ^c   Roth, J ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Anorexia; Antipyretics; Critical illness; Cytokines; Hyperalgesia; Immune to brain communication; Infancy; Inflammation; Influenza; Lethargy; Lipopolysaccharide; Non steroidal anti inflammatory drugs; Pregnancy; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; CYCLOOXYGENASE 2; DICLOFENAC POTASSIUM; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PROSTAGLANDIN E2;

ANOREXIA; BACTERIAL CLEARANCE; BEHAVIOR CHANGE; COGNITIVE DEFECT; COMMON COLD; CRITICAL ILLNESS; CYTOKINE RELEASE; DROWSINESS; DRUG OVERDOSE; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; HYPERTHERMIA; ILLNESS BEHAVIOR; INFLUENZA; LISTLESSNESS; MALAISE; MORTALITY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SEPSIS; SLEEP DISORDER; SURVIVAL RATE; THERMOGENESIS; UPPER RESPIRATORY TRACT INFECTION; VIRUS SHEDDING; VIRUS TRANSMISSION; ADOLESCENT; ADULT; ANIMAL; BRAIN; CHILD; COMPLICATION; FEMALE; INFANT; INFLAMMATION; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIPYRETICS; BRAIN; CHILD; COMMON COLD; FEMALE; FEVER; HUMANS; ILLNESS BEHAVIOR; INFANT; INFANT, NEWBORN; INFLAMMATION; INFLUENZA, HUMAN; MIDDLE AGED; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84937684786     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.07.012     Document Type: Review

References (147)

1. Abe M., Oka T., Hori T., Takahashi S. Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats. Brain Res. 2001, 916:41-49.
2. Bachert C., Chuchalin A.G., Eisebitt R., Netayzhenko V.Z., Voelker M. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin. Ther. 2005, 27:993-1003.
3. Benson V., Marano M.A. Current estimates from the National Health Interview Survey 1995. Vital Health Stat. 1998, 10:1-428.
4. Bernard G.R., Wheeler A.P., Russel J.A., Schein R., Summer W.R., Steinberg K.P., Fulkerson W.J., Wright P.E., Christman B.W., Dupont W.D., Higgins S.B., Swindell B.B. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in sepsis study group. N. Engl. J. Med. 1997, 336:912-918.
5. Bernheim H.A., Kluger M.J. Fever: effect of drug-induced antipyresis on survival. Science 1976, 193:237-239.
6. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006, 12:250-275.
7. Beutler B.A. TLRs and innate immunity. Blood 2009, 113:1399-1407.
8. Beutler B.A., Grau G.E. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 1993, 21:S423-S435.
9. Bilbo S.D. Frank A. Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system. Horm. Behav. 2013, 63:684-691.
10. Bilbo S.D., Schwarz J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 2012, 33:267-286.
11. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25:8000-8009.
12. Blatteis C.M. Fever: pathological or physiological, injurious or beneficial?. J. Therm. Biol 2003, 28:1-13.
13. Blatteis C.M. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol. Ther. 2006, 111:194-223.
14. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
15. Branco L.G., Soriano R.N., Steiner A.A. Gaseous mediators in thermoregulation. Compr. Physiol. 2014, 4:1301-1338.
16. Carpentier P.A., Palmer T.D. Immune influence on adult neural stem cell regulation and function. Neuron 2009, 64:79-92.
17. Chambers C.D., Johnson K.A., Dick L.M., Felix R.J., Jones K.L. Maternal fever and birth outcome: a prospective study. Teratology 1998, 58:251-257.
18. Chung S. Febrile seizures. Korean J. Pediatr. 2014, 57:384-395.
19. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 1991, 542:330-335.
20. Cross J.H. Fever and fever-related epilepsies. Epilepsia 2012, 53(Suppl. 4):3-8.
21. D'Mello C., Riazi K., Le T., Stevens K.M., Wang A., McKay D.M., Pittman Q.J., Swain M.G. P-selectin mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors. J. Neurosci. 2013, 33:14878-14888.
22. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci. 2001, 933:222-234.
23. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
24. Dean S.L., Knutson J.F., Krebs-Kraft D.L., McCarthy M.M. Prostaglandin E2 is an endogenous modulator of cerebellar development and complex behavior during a sensitive postnatal period. Eur. J. Neurosci. 2012, 35:1218-1229.
25. Desai M., ter Kuile F.O., Nosten F., McGready R., Asamoa K., Brabin B., Newman R.D. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 2007, 7:93-104.
26. Earn D.J., Andrews P.W., Bolker B.M. Population-level effects of suppressing fever. Proc. Biol. Sci. 2014, 281:20132570.
27. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 2005, 5:718-725.
28. Eccles R., Loose I., Jawad M., Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med. 2003, 4:118-124.
29. Edwards M.J. Review: hyperthermia and fever during pregnancy. Birth Defects Res. A Clin. Mol. Teratol. 2006, 76:507-516.
30. Engström Ruud L., Wilhelms D.B., Eskilsson A., Vasilache A.M., Elander L., Engblom D., Blomqvist A. Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2. Neuropharmacology 2013, 71:124-129.
31. Epstein N.N. Artificial fever as a therapeutic procedure. Cal. West. Med. 1936, 44:357-358.
32. Evans S.S., Repasky E.A., Fisher D.T. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat. Rev. Immunol. 2015, 15:335-349.
33. Fieren M.W.J., Van Den Bemd G.J., Ben-Efraim C.M., Bonta I.L. Prostaglandin E2 inhibits the release of tumor necrosis factor-α rather than interleukin 1β from human macrophages. Immunol. Lett. 1991, 31:85-90.
34. Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front. Neuroendocrinol. 2012, 33:116-125.
35. Gehanno P., Dreiser R.L., Ionescu E., Gold M., Liu J.M. Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat. Clin. Drug Investig. 2003, 23:263-271.
36. Goelst K., Mitchell D., Laburn H. Fever responses in newborn lambs. Pflugers Arch. 1992, 421:299-301.
37. Goto M., Kawamura T., Shimbo T., Takahashi O., Ando M., Miyaki K., Nohara T., Watanabe H., Suzuki I., Aono M. Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial. Intern. Med. 2007, 46:1179-1186. for the Great Cold Investigators-II.
38. Gozzoli V., Treggiari M.M., Kleger G.-R., Roux-Lombard P., Fathi M., Pichard C., Romand J.-A. Randomized trial on the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med. 2004, 30:401-407.
39. Graham N.M., Burrell C.J., Douglas R.M., Debelle P., Davies L. Effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J. Infect. Dis. 1990, 162:1277-1282.
40. Grebe W., Ionescu E., Gold M.S., Liu J.M., Frank W.O. A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms. Clin. Ther. 2003, 25:444-458.
41. Greer D.M., Funk S.E., Reaven N.L., Ouzounelli M., Uman G.C. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 2008, 39:3029-3035.
42. Hamoen M., Broekhuizen B.D., Little P., Melbye H., Coenen S., Goossens H., Butler C.C., Francis N.A., Verheij T.J. Medication use in European primary care patients with lower respiratory tract infection: an observational study. Br. J. Gen. Pract. 2014, 64:e81-91. GRACE clinical study group.
43. Harden L.M., du Plessis I., Roth J., Loram L.C., Poole S., Laburn H.P. Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology 2011, 36:608-622.
44. Harris W.H., Pittman Q.J., Veale W.L., Cooper K.E., Van Petten G.R. Cardiovascular effects of fever in the ewe and fetal lamb. Am. J. Obstet. Gynecol. 1977, 128:262-265.
45. Harvey L., Boksa P. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev. Neurobiol. 2012, 72:1335-1348.
46. Hasday J.D., Thompson C., Singh I.S. Fever, immunity, and molecular adaptations. Compr. Physiol. 2014, 4:109-148.
47. Heida J.G., Teskey G.C., Pittman Q.J. Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia 2005, 46:1898-1905.
48. Hobohm U. Fever therapy revisited. Br. J. Cancer 2005, 92:421-425.
49. Husseini R.H., Sweet C., Collie M.H., Smith H. Elevation of Nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J. Infect. Dis. 1982, 145:520-524.
50. Jain N.K., Patil C.S., Kulkarni S.K., Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav. Brain Res. 2002, 133:369-376.
51. Jiang Q., Cross A.S., Singh I.S., Chen T.T., Viscardi R.M., Hasday J.D. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect. Immun. 2000, 68:1265-1270.
52. Johnson R.W., von Borell E. Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin. J. Anim. Sci. 1994, 72:309-314.
53. Kentner A.C., Pittman Q.J. Minireview: early-life programming by inflammation of the neuroendocrine system. Endocrinology 2010, 151:4602-4606.
54. Khandaker G.M., Zimbron J., Lewis G., Jones P.B. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol. Med. 2013, 43:239-257.
55. Kim S.Y., Chang Y.J., Cho H.M., Hwang Y.W., Moon Y.S. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst. Rev. 2013, (6). CD006362.
56. Kluger M.J., Ringler D.H., Anver M.R. Fever and survival. Science 1975, 188:166-168.
57. Kluger M.J., Kozak W., Conn C.A., Leon L.R., Soszynski D. The adaptive value of fever. Infect. Dis. Clin. North Am. 1996, 10:1-20.
58. Kneeland R.E., Fatemi S.H. Viral infection, inflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:35-48.
59. Kourtis A.P., Read J.S., Jamieson D.J. Pregnancy and infection. N. Engl. J. Med. 2014, 370:2211-2218.
60. Kramer M.S., Naimark L.E., Roberts-Bräuer R., McDougall A., Leduc D.G. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991, 9:591-594.
61. 2. Biochem. Biophys. Res. Commun. 1986, 137:404-411.
62. Kushimoto S., Gando S., Saitoh D., Mayumi T., Ogura H., Fujishima S., Araki T., Ikeda H., Kotani J., Miki Y., Shirashi S., Suzuki K., Suzuki Y., Takeyama N., Takuma K., Tsuruta R., Yamagushi Y., Yamashita N., Aikawa N. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Crit. Care 2013, 17:271. JAAM Sepsis Registry (JAAMSR) Study Group.
63. Laburn H.P., Mitchell D., Goelst K. Fetal and maternal body temperatures measured by radiotelemetry in near-term sheep during thermal stress. J. Appl. Physiol. 1992, 72:894-900.
64. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999, 818:291-303.
65. Langhans W., Savoldelli D., Weingarten S. Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol. Behav. 1993, 53:643-649.
66. Launey Y., Nesseler N., Mallédant Y., Seguin P. Clinical review: fever in septic ICU patients - friend or foe?. Crit. Care 2011, 15:222.
67. Lee B.H., Inui D., Suh G.Y., Kim J.Y., Kwon J.Y., Park J., Tada K., Tanaka K., Ietsugu K., Uehara K., Dote K., Tajimi K., Morita K., Matsuo K., Hoshino K., Hosokawa K., Lee K.M., Takatori M., Nishimura M., Sanui M., Ito M., Egi M., Honda N., Okayama N., Shime N., Tsuruta R., Nogami S., Yoon S.-H., Fujitani S., Koh S.O., Takeda S., Saito S., Hong S.J., Yamamoto T., Yokohama T., Yamaguchi T., Nishiyama T., Igarashi T., Kakihana Y., Koh Y. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit. Care 2012, 16:33. Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group.
68. Li Z., Ren A., Liu J., Pei L., Zhang L., Guo Z., Li Z. Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in northern China. Birth Defects Res. A 2007, 79:295-300.
69. Lieberman E., Lang J., Richardson D.K., Frigoletto F.D., Heffner L.J., Cohen A. Intrapartum maternal fever and neonatal outcome. Pediatrics 2000, 105:8-13.
70. Lin M.T., Lin J.H. Involvement of tyrosine kinase in the pyrogenic fever exerted by NOS pathways in organum vasculosum laminae terminalis. Neuropharmacology 2000, 39:347-352.
71. Liu E., Lewis K., Al-Saffar H., Krall C.M., Singh A., Kulchitsky V.A., Corrigan J.J., Simons C.T., Petersen S.R., Musteasta F.M., Bakshi C.S., Romanovsky A.A., Sellati T.J., Steiner A.A. Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R1372-R1383.
72. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R862-868.
73. Mackowiak P.A. Direct effects of physiologic variations in temperature on pathogenic microorganisms. Fever: Basic Mechanisms and Management 1991, 167-182. Raven Press, New York. P.A. Mackowiak (Ed.).
74. Mackowiak P.A. Concepts of fever. Arch. Intern. Med. 1998, 158:1870-1881.
75. Marodi L. Neonatal innate immunity to infectious agents. Infect. Immun. 2006, 74:1999-2006.
76. Martich G.D., Danner R.L., Ceska M., Suffredini A.F. Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J. Exp. Med. 1991, 173:1021-1024.
77. Matsumura K., Kobayashi S. Signaling the brain in inflammation: the role of endothelial cells. Front. Biosci. 2004, 9:2819-2826.
78. McCusker R.H., Kelley K.W. Immune-neural connections: how the immune system's response to infectious agents influences behaviour. J. Exp. Biol. 2013, 216:84-98.
79. Memoli M.J., Harvey H., Morens D.M., Taubenberger J.K. Influenza in pregnancy. Influenza Other Respir. Viruses 2013, 7:1033-1039.
80. Meremikwu M.M., Oyo-Ita A. Paracetamol versus placebo or physical methods for treating fever in children. Cochrane Database Syst. Rev. Issue 2002, (2). Art. No.: CD003676.
81. Mertz D., Kim T.H., Johnstone J., Lam P.P., Science M., Kuster S.P., Fadel S.A., Tran D., Fernandez E., Bhatnagar N., Loeb M. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013, 347:f5061.
82. Meyer U. Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 2014, 75:307-315.
83. Miller M.W., Church C.C., Miller R.K., Edwards M.J. Fetal thermal dose considerations during the obstetrician's watch: implications for the pediatrician's observations. Birth Defects Res. C Embryo. Today 2007, 81:135-143.
84. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defences. Clin. Microbiol. Rev. 2009, 22:240-273.
85. Monto A.S. Epidemiology of viral respiratory infections. Am. J. Med. 2002, 112(Suppl. 6A):4S-12S.
86. Moore E.R., Anderson G.C., Bergman N., Dowswell T. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst. Rev. 2012, 22(3):CD003519.
87. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010, 63:425-433.
88. Moretti M.E., Bar-Oz B., Fried S., Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 2005, 16:216-219.
89. Mouihate A. Prenatal immune stress in rats dampens fever during adulthood. Dev. Neurosci. 2012, 34:318-326.
90. Mouihate A., Boissé L., Pittman Q.J. A novel antipyretic action of 15-deoxy-delta 12, 14-prostaglandin J2 in the rat brain. J. Neurosci. 2004, 24:1312-1318.
91. Mouihate A., Harre E.M., Martin S., Pittman Q.J. Suppression of the febrile response in late gestation: evidence, mechanisms and outcomes. J. Neuroendocrinol. 2008, 20:508-514.
92. Nakamura K. Central circuitries for body temperature regulation and fever. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1207-R1228.
93. Niven D.J., Stelfox H.T., Laupland K.B. Antipyretic therapy in febrile critically ill adults: a systematic review and meta-analysis. J. Crit. Care 2013, 28:303-310.
94. Offringa M., Newton R. Prophylactic drug management for febrile seizures in children (Review). Evid. Based. Child Health 2013, 8:1376-1485.
95. Ostberg J.R., Gellin R., Patel R., Repasky E.A. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J. Immunol. 2001, 167:2666-2670.
96. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society and Health Protection Agency in collaboration with the Department of Health. Thorax 2007, 62(Suppl. 1):1-46.
97. Patterson K.P., Baram T.Z., Shinnar S. Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus. Neurotherapeutics 2014, 11:242-250.
98. Pecchi E., Dallaporta M., Jean A., Thirion S., Troadec J.-D. Prostaglandins and sickness behaviour: old story, new insights. Physiol. Behav. 2009, 97:279-292.
99. Petrova A., Demissie K., Rhoads G.G., Smulian J.C., Marcella S., Ananth C.V. Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet. Gynecol. 2001, 98:20-27.
100. 2 production in response to TNF-α. FASEB J. 2003, 17:1411-1421.
101. Pillay V., Savage N., Laburn H. Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults. Pflugers Arch. 1994, 428:197-201.
102. Pineda E., Shin D., You S.J., Auvin S., Sankar R., Mazarati A. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann. Neurol. 2013, 74:11-19.
103. Pittman Q.J., Cooper K.E., Veale W.L., Van Petten G.R. Fever in newborn lambs. Can. J. Physiol. Pharmacol. 1973, 51:868-872.
104. Pittman Q.J., Cooper K.E., Veale W.L., Van Petten G.R. Observations on the development of the febrile response to pyrogens in sheep. Clin. Sci. Mol. Med. 1974, 46:591-602.
105. Quan N. In-depth conversation: spectrum and kinetics of neuroimmune afferent pathways. Brain Behav. Immun. 2014, 40:1-8.
106. Reid A.Y., Galic M.A., Teskey G.C., Pittman Q.J. Febrile seizures: current views and investigations. Can. J. Neurol. Sci. 2009, 36:679-686.
107. Reid A.Y., Pittman Q.J., Teskey G.C. A prolonged experimental febrile seizure results in motor map reorganization in adulthood. Neurobiol. Dis. 2012, 45:692-700.
108. Reid A.Y., Riazi K., Campbell T.G., Pittman Q.J. Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia 2013, 54:e45-e48.
109. Rice P., Martin E., He J.-R., Frank M., DeTolla L., Hester L., O'Neill T., Manka C., Benjamin I., Nagarsekar A., Singh I., Hasday J.D. Febrile range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental Gram-negative bacterial pneumonia. J. Immunol. 2005, 174:3676-3685.
110. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
111. Romanovsky A.A., Székely M. Fever and hypothermia: two adaptive thermoregulatory responses to systemic inflammation. Med. Hypotheses 1998, 50:219-226.
112. Romanovsky A., Almeida M.C., Aronoff D.M., Ivanov A.I., Konsman J.P., Steiner A.A., Turek V.F. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front. Biosci. 2005, 10:2193-2216.
113. Rosenspire A.J., Kindzelskii A.L., Petty H.R. Cutting edge: fever-associated temperatures enhance neutrophil responses to lipopolysaccharide: a potential mechanisms involving cell metabolism. J. Immunol. 2002, 169:5396-5400.
114. Roth J. Endogenous antipyretics. Clin. Chim. Acta 2006, 371:13-24.
115. Roth J., Blatteis C.M. Mechanisms of fever production and lysis: lessons from experimental LPS fever. Compr. Physiol. 2014, 4:1563-1604.
116. Roth J., Hübschle T., Pehl U., Ross G., Gerstberger R. Influence of systemic treatment with cyclooxygenase inhibitors on lipopolysaccharide-induced fever and circulating levels of cytokines and cortisol in guinea pigs. Pflügers Arch. - Eur. J. Physiol. 2002, 443:411-417.
117. Roth J., Harré E.M., Rummel C., Gerstberger R., Hübschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front. Biosci. 2004, 9:290-300.
118. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
119. Saper C.B., Romanovsky A.A., Scammell T.E. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci. 2012, 15:1088-1095.
120. Schachtel B.P., Thoden W.R. A placebo-controlled model for assaying systemic analgesics in children. Clin. Pharmacol. Ther. 1993, 53:593-601.
121. Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J. Biol. Chem. 2014, 289:35237-35245.
122. Schortgen F., Clabault K., Katsahian S., Devaquet J., Mercat A., Deye N., Dellamonica J., Bouadma L., Cook F., Beji O., Brun-Buisson C., Lemaire F., Brochard L. Fever control using external cooling in septic shock: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2012, 185:1088-1095.
123. Schuchmann S., Schmitz D., Rivera C., Vanhatalo S., Salmen B., Mackie K., Sipila S.T., Voipio J., Kaila K. Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat. Med. 2006, 12:817-823.
124. Schulman C.I., Namias N., Doherty J., Manning R.J., Li P., Elhaddad A., Lasko D., Amortegui J., Dy C.J., Dlugasch L., Baracco G., Cohn S.M. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg. Infect. 2005, 6:369-375.
125. Skitzki J.J., Chen Q., Wang W.C., Evans S.S. Primary immune surveillance: some like it hot. J. Mol. Med. 2007, 85:1361-1367.
126. Smith A.P., Nutt D.J. Effects of upper respiratory tract illnesses, ibuprofen and caffeine on reaction time and alertness. Psychopharmacology (Berl.) 2014, 231:1963-1974.
127. Spencer S.J., Mouihate A., Galic M.A., Pittman Q.J. Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J. Physiol. 2008, 586:399-406.
128. Spencer S.J., Galic M.A., Pittman Q.J. Neonatal programming of innate immune function. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E11-E18.
129. Sperber S.J., Hendley J.O., Hayden F.G., Riker D.K., Sorrentino J.V., Gwaltney J.M. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann. Intern. Med. 1992, 117:37-41.
130. Stanley E.D., Jackson G.G., Panusarn C., Rubenis M., Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 1975, 231:1248-1251.
131. Steiner A.A., Rudaya A.Y., Ivanov A.I., Romanovsky A.A. Febrigenic signaling to the brain does not involve nitric oxide. Br. J. Pharmacol. 2004, 141:1204-1213.
132. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav. Immun. 2010, 24:409-419.
133. Thompson H.J., Tkacs N.C., Saatman K.E., Raghupathi R., McIntosh T.K. Hyperthermia following traumatic brain injury: a critical evaluation. Neurobiol. Dis. 2003, 12:163-173.
134. Töllner B., Roth J., Störr B., Martin D., Voigt K., Zeisberger E. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of LPS. Pflügers Arch. - Eur. J. Physiol. 2000, 444:925-932.
135. Vasilache, A.M., Qian, H., Blomqvist, A., 2015. Immune challenge by intraperitoneal administration of lipopolysaccharide directs gene expression in distinct blood-brain barrier cells towards enhanced prostaglandin E2 signaling. Brain Behav. Immun. 48, 31-41.
136. Vezzani A., Aronica E., Mazarati A., Pittman Q.J. Epilepsy and brain inflammation. Exp. Neurol. 2011, 244:11-21.
137. Wagner-Jauregg J. Fieber- und Infektionstherapie von Nerven- und Geisteskrankheiten [Fever and infection treatment for neurological and mental illnesses]. Wiener Med. Wochenschr. 1930, 20:651-654.
138. Whitrow M. Wagner-Jauregg and fever therapy. Med. Hist. 1990, 34:294-310.
139. World Health Organization. 2009. Clinical management of human infection with pandemic (H1N1): revised guidance.
140. Wilhelms D.B., Kirilov M., Mirrasekhian E., Eskilsson A., Kugelberg U.Ö., Klar C., Ridder D.A., Herschman H.R., Schwaninger M., Blomqvist A. Deletion of prostaglandin E2 synthesizing enzymes in brain endothelial cells attenuates inflammatory fever. J. Neurosci. 2014, 34:11684-11690.
141. Winberg J. Mother and newborn baby: mutual regulation of physiology and behavior - a selective review. Dev. Psychobiol. 2005, 47:217-229.
142. Winther B., Mygind N. The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds. Am. J. Rhinol. 2001, 15:239-242.
143. Wong T., Stang A.S., Ganshorn H., Hartling L., Maconochie I.K., Thomsen A.M., Johnson D.W. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid. Based Child Health 2014, 9:675-729.
144. Yager J.Y., Asselin J. The effect of pre hypoxic-ischemic (HI) hypo and hyperthermia on brain damage in the immature rat. Brain Res. Dev. Brain Res. 1999, 117:139-143.
145. Yoneyama Y., Sawa R., Kubonoya K., Suzuki S., Otsubo Y., Power G.G., Araki T. Evidence for mechanisms of the acute-phase response to endotoxin in late-gestation fetal goats. Am. J. Obstet. Gynecol. 1998, 179:750-755.
146. Young P.J., Saxena M., Beasley R., Bellomo R., Bailey M., Pilcher D., Finfer S., Harrison D., Myburgh J., Rowan K. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012, 38:437-444.
147. Zhang J., Rivest S. Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J. Neurochem. 2001, 76:855-864.